BF BIOSCIENCE LTD
Pharmaceutical company · 10 brands · 24 molecules
Ranked #31 of 44 companies in Antineoplastics
Company overview
BF BIOSCIENCE LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 10 product registrations across 24 distinct molecules. Its portfolio is concentrated in Antineoplastics and Cancer. DRAP has issued 2 alerts involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Products by BF
4 products matched in our catalogue — each with its observed price and DRAP approved ceiling.
Price ceiling age
DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.
Top molecules by brand count
Therapeutic classes
Conditions treated
Price band (DRAP official ceilings)
Regulatory record
2 alerts in the DRAP feed we track.
Competitive set
Companies whose registered portfolio overlaps most with this one.
Get the full profile for BF
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.
Request this brief See what’s included